Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis.
Fadul CE, Mao-Draayer Y, Ryan KA, Noelle RJ, Wishart HA, Channon JY, Kasper IR, Oliver B, Mielcarz DW, Kasper LH. Fadul CE, et al. Among authors: noelle rj. Neurol Neuroimmunol Neuroinflamm. 2021 Oct 15;8(6):e1096. doi: 10.1212/NXI.0000000000001096. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34654708 Free PMC article. Clinical Trial.
Immune regulation by CD40 and its ligand GP39.
Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. Foy TM, et al. Among authors: noelle rj. Annu Rev Immunol. 1996;14:591-617. doi: 10.1146/annurev.immunol.14.1.591. Annu Rev Immunol. 1996. PMID: 8717526 Review.
CD40 and its ligand.
Clark LB, Foy TM, Noelle RJ. Clark LB, et al. Among authors: noelle rj. Adv Immunol. 1996;63:43-78. doi: 10.1016/s0065-2776(08)60854-8. Adv Immunol. 1996. PMID: 8787629 Review. No abstract available.
IL-9 as a mediator of Th17-driven inflammatory disease.
Nowak EC, Weaver CT, Turner H, Begum-Haque S, Becher B, Schreiner B, Coyle AJ, Kasper LH, Noelle RJ. Nowak EC, et al. Among authors: noelle rj. J Exp Med. 2009 Aug 3;206(8):1653-60. doi: 10.1084/jem.20090246. Epub 2009 Jul 13. J Exp Med. 2009. PMID: 19596803 Free PMC article.
A randomized trial of ex vivo CD40L activation of a dendritic cell vaccine in colorectal cancer patients: tumor-specific immune responses are associated with improved survival.
Barth RJ Jr, Fisher DA, Wallace PK, Channon JY, Noelle RJ, Gui J, Ernstoff MS. Barth RJ Jr, et al. Among authors: noelle rj. Clin Cancer Res. 2010 Nov 15;16(22):5548-56. doi: 10.1158/1078-0432.CCR-10-2138. Epub 2010 Sep 30. Clin Cancer Res. 2010. PMID: 20884622 Free PMC article. Clinical Trial.
267 results